NIH News Releases

Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers

NIH trial shows new form of TIL therapy effective against colon, rectum, pancreas, and bile duct tumors.

Apr 1, 2025 - 15:47
 0
Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers
NIH trial shows new form of TIL therapy effective against colon, rectum, pancreas, and bile duct tumors.
Read More

Tags:

Previous Article

Jay Bhattacharya Begins Tenure as 18th Director of the National Institutes of He...

Next Article

Capri Holdings loses CFO

Related Posts

NIH researchers develop eye drops that slow vision loss in animals

NIH researchers develop eye drops that slow vision loss...

Mar 21, 2025  0

Jay Bhattacharya Begins Tenure as 18th Director of the National Institutes of Health

Jay Bhattacharya Begins Tenure as 18th Director of the ...

Apr 1, 2025  0

Surgery in kids with mild sleep-disordered breathing tied to fewer doctor visits, meds

Surgery in kids with mild sleep-disordered breathing ti...

Mar 17, 2025  0